Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07087405 · ClinicalTrials.gov registry record · NA
Striae Distensae Treatment Using Deep Skin Abrasion
A NA study, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07087405: Recruiting NA study, sponsored by Boston Children's Hospital.
NCT07087405 is a NA study that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07087405, a NA study, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a device works to treat striae distensae. It will also learn about the safety of the device. The main questions it aims to answer are: 1. Does the device improve the appearance of striae distensae? 2. Does the device cause any problems when treating striae distensae? Researchers will compare the appearance of striae distensae before and after treatment with the device. Participants will: 1. Undergo treatment with the device in the clinic 2. Visit the clinic 1 week, 3 months, and 1 year for checkups and tests
Primary Outcome
Comparison of photographs before and after treatment
Interventions
- DEVICE Striae Distensae Treatment Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT07087405 shows while recruiting
NCT07087405 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Striae Distensae Treatment Device is the first listed.
NCT07087405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07087405 about?
NCT07087405 is a clinical study titled "Striae Distensae Treatment Using Deep Skin Abrasion". The goal of this clinical trial is to learn if a device works to treat striae distensae. It will also learn about the safety of the device. The main questions it aims to answer are: 1. Does the device improve the appearance of striae distensae? 2. Does the device cause any problems when treating st...
What is the current status of trial NCT07087405?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-10-01. Estimated completion is 2026-12-01.
What interventions are being tested in trial NCT07087405?
The interventions under investigation include: Striae Distensae Treatment Device (DEVICE).
Who is sponsoring clinical trial NCT07087405?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07087405's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI